These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38919029)

  • 1. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
    Liao X; Fan R
    Hepatology; 2024 Sep; 80(3):E46-E47. PubMed ID: 38919029
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
    Luo C
    Hepatology; 2024 Oct; 80(4):E57. PubMed ID: 38743007
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk-A multinational cohort study of HBeAg-positive patients.
    He T; Zhang D
    Hepatology; 2024 Aug; 80(2):E26-E27. PubMed ID: 38607724
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of Patients with HBeAg-Positive.
    Choi WM; Lim YS
    Hepatology; 2024 Aug; 80(2):E28. PubMed ID: 38607785
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
    Choi WM; Yip TC; Kim WR; Yee LJ; Brooks-Rooney C; Curteis T; Clark LJ; Jafry Z; Chen CH; Chen CY; Huang YH; Jin YJ; Jun DW; Kim JW; Park NH; Peng CY; Shin HP; Shin JW; Yang YH; Wong GL; Lim YS
    Hepatology; 2024 Aug; 80(2):428-439. PubMed ID: 38436992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closing the Stable Door After the Horse Has Bolted: Should We Be Treating People With Immune-Tolerant Chronic Hepatitis B to Prevent Hepatocellular Carcinoma?
    Howell J; Chan HLY; Feld JJ; Hellard ME; Thompson AJ
    Gastroenterology; 2020 Jun; 158(8):2028-2032. PubMed ID: 32088205
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
    Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
    World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B.
    Bekku D; Arai M; Imazeki F; Yonemitsu Y; Kanda T; Fujiwara K; Fukai K; Sato K; Itoga S; Nomura F; Yokosuka O
    J Gastroenterol Hepatol; 2011 Jan; 26(1):122-8. PubMed ID: 21175805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B.
    Nam JY; Chang Y; Cho H; Kang SH; Cho YY; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
    J Viral Hepat; 2018 May; 25(5):552-560. PubMed ID: 29194870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.
    Seo Y; Yano Y
    World J Gastroenterol; 2014 Oct; 20(37):13284-92. PubMed ID: 25309065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis B: Evolution over two decades.
    Yuen MF; Lai CL
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B: still needs further discussion.
    He T; Zhang D
    Gut; 2024 Oct; 73(11):e28. PubMed ID: 38253480
    [No Abstract]   [Full Text] [Related]  

  • 13. Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors.
    Cunha-Silva M; Marinho FRT; Oliveira PF; Lopes TM; Sevá-Pereira T; Lorena SLS; Almeida JRS
    Braz J Infect Dis; 2017; 21(4):441-447. PubMed ID: 28554002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance.
    Fung J; Cheung KS; Wong DK; Mak LY; To WP; Seto WK; Lai CL; Yuen MF
    Hepatology; 2018 Aug; 68(2):462-472. PubMed ID: 29534307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the key outcomes and hepatocellular carcinoma risk in patients in immune-tolerant phase of chronic hepatitis B virus infection: A systematic review and meta-analysis.
    Liu M; Zhao T; Zhang J; Bu B; Zhang R; Xia X; Geng J
    Rev Med Virol; 2024 Jul; 34(4):e2570. PubMed ID: 38964866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term history of chronic hepatitis B virus infection in children].
    Fujisawa T; Inui A; Sogo T; Komatsu H
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():303-8. PubMed ID: 15453335
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of HBeAg negative chronic hepatitis B].
    Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):539. PubMed ID: 16042896
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.
    Choi WM; Kim GA; Choi J; Choi GH; Lee YB; Sinn DH; Lim YS
    Gut; 2024 Mar; 73(4):649-658. PubMed ID: 37813567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ
    J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection.
    Gu S; Fu X; Ye G; Chen C; Li X; Zhong S; Tang L; Chen H; Jiang D; Hou J; Li Y
    Front Immunol; 2021; 12():649197. PubMed ID: 34234772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.